BC
NPSP

Broadfin Capital’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Broadfin Capital’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-400,000
Closed -$12.1M – 95
2013
Q4 		$12.1M Sell
400,000
-51,597
-11% -$1.42M 1.6% 24
2013
Q3 		$14.4M Sell
451,597
-1,245,157
-73% -$28.6M 2.55% 16
2013
Q2 		$25.6M Buy
+1,696,754
New +$23.5M 5.02% 7

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Broadfin Capital's NPSP Position: Q1 2014 in Review

Broadfin Capital sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2014, closing a stake of 400,000 shares — an estimated $12.1M sold.

Broadfin Capital first reported a position in NPSP in Q2 2013 and held it in 3 quarters. The position peaked at $25.6M in Q2 2013. 210 funds tracked by Wall St. Rank hold NPSP as of Q1 2014.

  • Broadfin Capital reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Broadfin Capital sold 400,000 NPS PHARMACEUTICALS INC shares in Q1 2014, an estimated $12.1M.
  • Broadfin Capital first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • Broadfin Capital's NPS PHARMACEUTICALS INC position peaked at $25.6M in Q2 2013.
  • 210 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2014.

Based on Broadfin Capital's 13F filing for Q1 2014, filed 15 May 2014.